Thomas J. Herzfeld Advisors’s Novartis NVS Stock Holding History

Thomas J. Herzfeld Advisors’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-1,200	Closed	-$116K	–	278
2023 Q3	$116K	Hold	1,200	–	–	0.04%	101
2023 Q2	$121K	Hold	1,200	–	–	0.05%	90
2023 Q1	$110K	Hold	1,200	–	–	0.04%	87
2022 Q4	$109K	Sell	1,200 -44	-4%	-$3.71K	0.04%	91
2022 Q3	$95K	Hold	1,244	–	–	0.04%	90
2022 Q2	$105K	Hold	1,244	–	–	0.04%	97
2022 Q1	$109K	Hold	1,244	–	–	0.04%	104
2021 Q4	$109K	Hold	1,244	–	–	0.04%	115
2021 Q3	$102K	Hold	1,244	–	–	0.05%	103
2021 Q2	$114K	Buy	1,244 +12	+1%	+$1.07K	0.05%	110
2021 Q1	$105K	Hold	1,232	–	–	0.05%	120
2020 Q4	$116K	Hold	1,232	–	–	0.05%	115
2020 Q3	$96K	Hold	1,232	–	–	0.06%	79
2020 Q2	$101K	Sell	1,232 -136	-10%	-$11.7K	0.05%	111
2020 Q1	$113K	Hold	1,368	–	–	0.06%	106
2019 Q4	$130K	Hold	1,368	–	–	0.05%	104
2019 Q3	$119K	Buy	1,368 +18	+1%	+$1.62K	0.04%	123
2019 Q2	$123K	Buy	1,350 +659	+95%	+$55.8K	0.05%	129
2019 Q1	$52K	Buy	691 +37	+6%	+$2.97K	0.02%	179
2018 Q4	$50K	Buy	654 +96	+17%	+$7.47K	0.02%	175
2018 Q3	$43K	Hold	558	–	–	0.02%	168
2018 Q2	$38K	Hold	558	–	–	0.01%	189
2018 Q1	$40K	Hold	558	–	–	0.02%	199
2017 Q4	$42K	Hold	558	–	–	0.02%	195
2017 Q3	$43K	Buy	+558	New	+$42.1K	0.02%	192

Other funds holding NVS

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Thomas J. Herzfeld Advisors's NVS Position: Q4 2023 in Review

Thomas J. Herzfeld Advisors sold out of Novartis (NVS) in Q4 2023, closing a stake of 1,200 shares — an estimated $116K sold.

Thomas J. Herzfeld Advisors first reported a position in NVS in Q3 2017 and held it in 25 quarters. The position peaked at $130K in Q4 2019. 1,272 funds tracked by Wall St. Rank hold NVS as of Q4 2023.

Thomas J. Herzfeld Advisors reported no remaining Novartis position as of Q4 2023 after selling out during the quarter.
Thomas J. Herzfeld Advisors sold 1,200 Novartis shares in Q4 2023, an estimated $116K.
Thomas J. Herzfeld Advisors first reported a position in Novartis in Q3 2017 and held it in 25 quarters.
Thomas J. Herzfeld Advisors's Novartis position peaked at $130K in Q4 2019.
1,272 funds tracked by Wall St. Rank held Novartis as of Q4 2023.

Based on Thomas J. Herzfeld Advisors's 13F filing for Q4 2023, filed 14 Feb 2024.